L. Prisăcariu

Hepatitis B coinfection in HIV-infected patients

C. Nicolau, Gabriela Jugănariu, L. Prisăcariu, 2013, BMC Infectious Diseases.

The psycho-emotional profile of the HIV-positive naïve patient.

C. Nicolau, L. Prisăcariu, C. Manciuc, 2014, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study.

A. Streinu-Cercel, S. Rugină, L. Prisăcariu, 2014, Germs.

The Clinical Utility of Circulating HPV DNA Biomarker in Oropharyngeal, Cervical, Anal, and Skin HPV-Related Cancers: A Review

L. Prisăcariu, I. Luchian, L. Iancu, 2023, Pathogens.

Treatment initiation or switch to BIC/FTC/TAF - real-world safety and efficacy data from two HIV centers in Romania.

L. Prisăcariu, C. Dorobăț, L. Preoțescu, 2021, Germs.